![LPV LPV](https://data.pdbj.org/pdbjplus/data/cc/svg/LPV.svg) | LPV | Name: | (2~{R},3~{S})-3-azanyl-~{N}-[(2~{R})-4-(4-butylphenoxy)-1-phenyl-butan-2-yl]-2-oxidanyl-butanamide | Formula: | C24 H34 N2 O3 | SMILES: | CCCCc1ccc(OCC[CH](Cc2ccccc2)NC(=O)[CH](O)[CH](C)N)cc1 | InChi: | InChI=1S/C24H34N2O3/c1-3-4-8-19-11-13-22(14-12-19)29-16-15-21(17-20-9-6-5-7-10-20)26-24(28)23(27)18(2)25/h5-7,9-14,18,21,23,27H,3-4,8,15-17,25H2,1-2H3,(H,26,28)/t18-,21-,23+/m0/s1 | Definition date: | 2022-07-07 | Last modified: | 2023-11-03 | Release date: | 2023-10-25 | Identifier: | (2~{R},3~{S})-3-azanyl-~{N}-[(2~{R})-4-(4-butylphenoxy)-1-phenyl-butan-2-yl]-2-oxidanyl-butanamide |
|
![LQ0 LQ0](https://data.pdbj.org/pdbjplus/data/cc/svg/LQ0.svg) | LQ0 | Name: | 2-(6-chloro-1H-indol-1-yl)-N-(4-methylpyridin-3-yl)acetamide | Formula: | C16 H14 Cl N3 O | SMILES: | Cc1ccncc1NC(=O)Cn1ccc2ccc(Cl)cc21 | InChi: | InChI=1S/C16H14ClN3O/c1-11-4-6-18-9-14(11)19-16(21)10-20-7-5-12-2-3-13(17)8-15(12)20/h2-9H,10H2,1H3,(H,19,21) | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(6-chloro-1H-indol-1-yl)-N-(4-methylpyridin-3-yl)acetamide |
|
![LQU LQU](https://data.pdbj.org/pdbjplus/data/cc/svg/LQU.svg) | LQU | Name: | 3-[(4R)-2-acetyl-1,2,3,4-tetrahydroisoquinolin-4-yl]benzonitrile | Formula: | C18 H16 N2 O | SMILES: | N#Cc1cccc(c1)C1CN(Cc2ccccc21)C(C)=O | InChi: | InChI=1S/C18H16N2O/c1-13(21)20-11-16-6-2-3-8-17(16)18(12-20)15-7-4-5-14(9-15)10-19/h2-9,18H,11-12H2,1H3/t18-/m1/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 3-[(4R)-2-acetyl-1,2,3,4-tetrahydroisoquinolin-4-yl]benzonitrile |
|
![LR0 LR0](https://data.pdbj.org/pdbjplus/data/cc/svg/LR0.svg) | LR0 | Name: | (7R)-N-(4-acetamidopyridin-3-yl)-4-fluorobicyclo[4.2.0]octa-1,3,5-triene-7-carboxamide | Formula: | C16 H14 F N3 O2 | SMILES: | O=C(Nc1cnccc1NC(C)=O)C1Cc2ccc(F)cc21 | InChi: | InChI=1S/C16H14FN3O2/c1-9(21)19-14-4-5-18-8-15(14)20-16(22)13-6-10-2-3-11(17)7-12(10)13/h2-5,7-8,13H,6H2,1H3,(H,20,22)(H,18,19,21)/t13-/m1/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (7R)-N-(4-acetamidopyridin-3-yl)-4-fluorobicyclo[4.2.0]octa-1,3,5-triene-7-carboxamide |
|
![LRC LRC](https://data.pdbj.org/pdbjplus/data/cc/svg/LRC.svg) | LRC | Name: | 2-(5-chloropyridin-3-yl)-N-(4-methylpyridin-3-yl)acetamide | Formula: | C13 H12 Cl N3 O | SMILES: | O=C(Nc1cnccc1C)Cc1cc(Cl)cnc1 | InChi: | InChI=1S/C13H12ClN3O/c1-9-2-3-15-8-12(9)17-13(18)5-10-4-11(14)7-16-6-10/h2-4,6-8H,5H2,1H3,(H,17,18) | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(5-chloropyridin-3-yl)-N-(4-methylpyridin-3-yl)acetamide |
|
![LRN LRN](https://data.pdbj.org/pdbjplus/data/cc/svg/LRN.svg) | LRN | Name: | 1-[(3R)-3-{(cyclohexylmethyl)[(1r,4R)-4-hydroxycyclohexyl]amino}piperidin-1-yl]ethan-1-one | Formula: | C20 H36 N2 O2 | SMILES: | O=C(C)N1CCCC(C1)N(CC1CCCCC1)C1CCC(O)CC1 | InChi: | InChI=1S/C20H36N2O2/c1-16(23)21-13-5-8-19(15-21)22(14-17-6-3-2-4-7-17)18-9-11-20(24)12-10-18/h17-20,24H,2-15H2,1H3/t18-,19-,20-/m1/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 1-[(3R)-3-{(cyclohexylmethyl)[(1r,4R)-4-hydroxycyclohexyl]amino}piperidin-1-yl]ethan-1-one |
|
![LS0 LS0](https://data.pdbj.org/pdbjplus/data/cc/svg/LS0.svg) | LS0 | Name: | 2-(6-fluoro-1H-indol-1-yl)-N-(4-methylpyridin-3-yl)acetamide | Formula: | C16 H14 F N3 O | SMILES: | Cc1ccncc1NC(=O)Cn1ccc2ccc(F)cc21 | InChi: | InChI=1S/C16H14FN3O/c1-11-4-6-18-9-14(11)19-16(21)10-20-7-5-12-2-3-13(17)8-15(12)20/h2-9H,10H2,1H3,(H,19,21) | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(6-fluoro-1H-indol-1-yl)-N-(4-methylpyridin-3-yl)acetamide |
|
![LSF LSF](https://data.pdbj.org/pdbjplus/data/cc/svg/LSF.svg) | LSF | Name: | N-(4-methylpyridin-3-yl)-2-(3-{[(2R)-4-oxoazetidin-2-yl]oxy}phenyl)acetamide | Formula: | C17 H17 N3 O3 | SMILES: | Cc1ccncc1NC(=O)Cc1cccc(OC2CC(=O)N2)c1 | InChi: | InChI=1S/C17H17N3O3/c1-11-5-6-18-10-14(11)19-15(21)8-12-3-2-4-13(7-12)23-17-9-16(22)20-17/h2-7,10,17H,8-9H2,1H3,(H,19,21)(H,20,22)/t17-/m1/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-(4-methylpyridin-3-yl)-2-(3-{[(2R)-4-oxoazetidin-2-yl]oxy}phenyl)acetamide |
|
![LSO LSO](https://data.pdbj.org/pdbjplus/data/cc/svg/LSO.svg) | LSO | Name: | (Z)-N~6~-(3-CARBOXY-1-{[(4-CARBOXY-2-OXOBUTYL)SULFONYL]METHYL}PROPYLIDENE)-L-LYSINE | Formula: | C16 H26 N2 O9 S | SMILES: | O=S(=O)(C/C(=N/CCCCC(C(=O)O)N)CCC(=O)O)CC(=O)CCC(=O)O | InChi: | InChI=1S/C16H26N2O9S/c17-13(16(24)25)3-1-2-8-18-11(4-6-14(20)21)9-28(26,27)10-12(19)5-7-15(22)23/h13H,1-10,17H2,(H,20,21)(H,22,23)(H,24,25)/b18-11+/t13-/m0/s1 | Synonyms: | 2-AMINO-6-[3-CARBOXY-2-OXO-BUTANE-1-SULFONYLMETHYL-PROPYLIDENEAMINO]-HEXANOIC ACID | Definition date: | 2005-09-11 | Last modified: | 2023-11-03 | Identifier: | (E)-N~6~-(3-carboxy-1-{[(4-carboxy-2-oxobutyl)sulfonyl]methyl}propylidene)-L-lysine |
|
![3TY 3TY](https://data.pdbj.org/pdbjplus/data/cc/svg/3TY.svg) | 3TY | Name: | 3-[(3E)-3-(BENZYLHYDRAZONO)-4-HYDROXY-6-OXOCYCLOHEXA-1,4-DIEN-1-YL]-L-ALANINE | Formula: | C16 H17 N3 O4 | SMILES: | O=C2C=C(O)/C(=N/NCc1ccccc1)C=C2CC(C(=O)O)N | InChi: | InChI=1S/C16H17N3O4/c17-12(16(22)23)6-11-7-13(15(21)8-14(11)20)19-18-9-10-4-2-1-3-5-10/h1-5,7-8,12,18,21H,6,9,17H2,(H,22,23)/b19-13+/t12-/m0/s1 | Definition date: | 2004-08-11 | Last modified: | 2023-11-03 | Identifier: | 3-[(3E)-3-(benzylhydrazono)-4-hydroxy-6-oxocyclohexa-1,4-dien-1-yl]-L-alanine |
|
![LT9 LT9](https://data.pdbj.org/pdbjplus/data/cc/svg/LT9.svg) | LT9 | Name: | 1-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)-3-oxocyclobutane-1-carboxamide | Formula: | C17 H15 Cl N2 O2 | SMILES: | O=C(Nc1cnccc1C)C1(CC(=O)C1)c1cccc(Cl)c1 | InChi: | InChI=1S/C17H15ClN2O2/c1-11-5-6-19-10-15(11)20-16(22)17(8-14(21)9-17)12-3-2-4-13(18)7-12/h2-7,10H,8-9H2,1H3,(H,20,22) | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 1-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)-3-oxocyclobutane-1-carboxamide |
|
![LTA LTA](https://data.pdbj.org/pdbjplus/data/cc/svg/LTA.svg) | LTA | Name: | 4,8-DIAMINO-3-HYDROXY-OCTANOIC ACID ETHYL ESTER | Formula: | C10 H22 N2 O3 | SMILES: | O=C(OCC)CC(O)C(N)CCCCN | InChi: | InChI=1S/C10H22N2O3/c1-2-15-10(14)7-9(13)8(12)5-3-4-6-11/h8-9,13H,2-7,11-12H2,1H3/t8-,9-/m0/s1 | Synonyms: | STATINE ANALOGUE | Definition date: | 1999-07-08 | Last modified: | 2023-11-03 | Identifier: | ethyl (3S,4S)-4,8-diamino-3-hydroxyoctanoate |
|
![3U0 3U0](https://data.pdbj.org/pdbjplus/data/cc/svg/3U0.svg) | 3U0 | Name: | 2-[4-(carbamimidamidomethyl)phenyl]ethanoic acid | Formula: | C10 H13 N3 O2 | SMILES: | NC(=N)NCc1ccc(CC(O)=O)cc1 | InChi: | InChI=1S/C10H13N3O2/c11-10(12)13-6-8-3-1-7(2-4-8)5-9(14)15/h1-4H,5-6H2,(H,14,15)(H4,11,12,13) | Synonyms: | 2-[4-[(diaminomethylideneamino)methyl]phenyl]acetic acid | Definition date: | 2014-10-24 | Last modified: | 2023-11-03 | Release date: | 2022-10-19 | Identifier: | 2-[4-(carbamimidamidomethyl)phenyl]ethanoic acid |
|
![I3D I3D](https://data.pdbj.org/pdbjplus/data/cc/svg/I3D.svg) | I3D | Name: | 5,6-difluoro-tryptophan | Formula: | C11 H10 F2 N2 O2 | SMILES: | N[CH](Cc1c[nH]c2cc(F)c(F)cc12)C(O)=O | InChi: | InChI=1S/C11H10F2N2O2/c12-7-2-6-5(1-9(14)11(16)17)4-15-10(6)3-8(7)13/h2-4,9,15H,1,14H2,(H,16,17)/t9-/m0/s1 | Synonyms: | (2S)-2-azanyl-3-[5,6-bis(fluoranyl)-1H-indol-3-yl]propanoic acid | Definition date: | 2022-02-10 | Last modified: | 2023-11-03 | Release date: | 2022-11-23 | Identifier: | (2~{S})-2-azanyl-3-[5,6-bis(fluoranyl)-1~{H}-indol-3-yl]propanoic acid |
|
![3V3 3V3](https://data.pdbj.org/pdbjplus/data/cc/svg/3V3.svg) | 3V3 | Name: | 1-amino-3,6,9,12-tetraoxapentadecan-15-oic acid | Formula: | C11 H23 N O6 | SMILES: | O=C(O)CCOCCOCCOCCOCCN | InChi: | InChI=1S/C11H23NO6/c12-2-4-16-6-8-18-10-9-17-7-5-15-3-1-11(13)14/h1-10,12H2,(H,13,14) | Definition date: | 2014-11-09 | Last modified: | 2023-11-03 | Release date: | 2015-02-11 | Identifier: | 1-amino-3,6,9,12-tetraoxapentadecan-15-oic acid |
|
![3V8 3V8](https://data.pdbj.org/pdbjplus/data/cc/svg/3V8.svg) | 3V8 | Name: | (4S)-4-[4-(2-carboxyethyl)-1H-1,2,3-triazol-1-yl]-L-proline | Formula: | C10 H14 N4 O4 | SMILES: | O=C(O)C2NCC(n1nnc(c1)CCC(=O)O)C2 | InChi: | InChI=1S/C10H14N4O4/c15-9(16)2-1-6-5-14(13-12-6)7-3-8(10(17)18)11-4-7/h5,7-8,11H,1-4H2,(H,15,16)(H,17,18)/t7-,8-/m0/s1 | Definition date: | 2014-11-12 | Last modified: | 2023-11-03 | Release date: | 2015-03-04 | Identifier: | (4S)-4-[4-(2-carboxyethyl)-1H-1,2,3-triazol-1-yl]-L-proline |
|
![3WT 3WT](https://data.pdbj.org/pdbjplus/data/cc/svg/3WT.svg) | 3WT | Name: | (3R,4S,5S)-3-methoxy-5-methyl-4-(methylamino)heptanoic acid | Formula: | C10 H21 N O3 | SMILES: | O=C(O)CC(OC)C(NC)C(C)CC | InChi: | InChI=1S/C10H21NO3/c1-5-7(2)10(11-3)8(14-4)6-9(12)13/h7-8,10-11H,5-6H2,1-4H3,(H,12,13)/t7-,8+,10-/m0/s1 | Definition date: | 2014-12-01 | Last modified: | 2023-11-03 | Release date: | 2015-03-25 | Identifier: | (3R,4S,5S)-3-methoxy-5-methyl-4-(methylamino)heptanoic acid |
|
![3YM 3YM](https://data.pdbj.org/pdbjplus/data/cc/svg/3YM.svg) | 3YM | Name: | 3-methoxy-L-tyrosine | Formula: | C10 H13 N O4 | SMILES: | O=C(O)C(N)Cc1cc(OC)c(O)cc1 | InChi: | InChI=1S/C10H13NO4/c1-15-9-5-6(2-3-8(9)12)4-7(11)10(13)14/h2-3,5,7,12H,4,11H2,1H3,(H,13,14)/t7-/m0/s1 | Definition date: | 2012-10-29 | Last modified: | 2023-11-03 | Release date: | 2013-10-30 | Identifier: | 3-methoxy-L-tyrosine |
|
![3ZH 3ZH](https://data.pdbj.org/pdbjplus/data/cc/svg/3ZH.svg) | 3ZH | Name: | 11-{4-[(2S)-2-amino-2-carboxyethyl]-3-(8-phenyloctyl)-2,3-dihydro-1H-imidazol-1-yl}undecanoic acid | Formula: | C31 H51 N3 O4 | SMILES: | O=C(O)C(N)CC1=CN(CCCCCCCCCCC(=O)O)CN1CCCCCCCCc2ccccc2 | InChi: | InChI=1S/C31H51N3O4/c32-29(31(37)38)24-28-25-33(22-16-9-5-2-1-3-8-15-21-30(35)36)26-34(28)23-17-10-6-4-7-12-18-27-19-13-11-14-20-27/h11,13-14,19-20,25,29H,1-10,12,15-18,21-24,26,32H2,(H,35,36)(H,37,38)/t29-/m0/s1 | Definition date: | 2014-12-12 | Last modified: | 2023-11-03 | Release date: | 2015-07-29 | Identifier: | 11-{4-[(2S)-2-amino-2-carboxyethyl]-3-(8-phenyloctyl)-2,3-dihydro-1H-imidazol-1-yl}undecanoic acid |
|
![40A 40A](https://data.pdbj.org/pdbjplus/data/cc/svg/40A.svg) | 40A | Name: | N-[(2S)-2-aminopropyl]-N-[(6-amino-9H-purin-9-yl)acetyl]glycine | Formula: | C12 H17 N7 O3 | SMILES: | O=C(O)CN(C(=O)Cn1c2ncnc(c2nc1)N)CC(N)C | InChi: | InChI=1S/C12H17N7O3/c1-7(13)2-18(4-9(21)22)8(20)3-19-6-17-10-11(14)15-5-16-12(10)19/h5-7H,2-4,13H2,1H3,(H,21,22)(H2,14,15,16)/t7-/m0/s1 | Definition date: | 2010-04-26 | Last modified: | 2023-11-03 | Identifier: | N-[(2S)-2-aminopropyl]-N-[(6-amino-9H-purin-9-yl)acetyl]glycine |
|
![40C 40C](https://data.pdbj.org/pdbjplus/data/cc/svg/40C.svg) | 40C | Name: | N-[(4-amino-2-oxopyrimidin-1(2H)-yl)acetyl]-N-[(2S)-2-aminopropyl]glycine | Formula: | C11 H17 N5 O4 | SMILES: | O=C(N(CC(=O)O)CC(N)C)CN1C=CC(=NC1=O)N | InChi: | InChI=1S/C11H17N5O4/c1-7(12)4-16(6-10(18)19)9(17)5-15-3-2-8(13)14-11(15)20/h2-3,7H,4-6,12H2,1H3,(H,18,19)(H2,13,14,20)/t7-/m0/s1 | Definition date: | 2010-04-26 | Last modified: | 2023-11-03 | Identifier: | N-[(4-amino-2-oxopyrimidin-1(2H)-yl)acetyl]-N-[(2S)-2-aminopropyl]glycine |
|
![40G 40G](https://data.pdbj.org/pdbjplus/data/cc/svg/40G.svg) | 40G | Name: | N-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)acetyl]-N-[(2S)-2-aminopropyl]glycine | Formula: | C12 H17 N7 O4 | SMILES: | O=C(O)CN(C(=O)Cn1c2N=C(NC(=O)c2nc1)N)CC(N)C | InChi: | InChI=1S/C12H17N7O4/c1-6(13)2-18(4-8(21)22)7(20)3-19-5-15-9-10(19)16-12(14)17-11(9)23/h5-6H,2-4,13H2,1H3,(H,21,22)(H3,14,16,17,23)/t6-/m0/s1 | Definition date: | 2010-04-26 | Last modified: | 2023-11-03 | Identifier: | N-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)acetyl]-N-[(2S)-2-aminopropyl]glycine |
|
![40T 40T](https://data.pdbj.org/pdbjplus/data/cc/svg/40T.svg) | 40T | Name: | N-[(2S)-2-aminopropyl]-N-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]glycine | Formula: | C12 H18 N4 O5 | SMILES: | O=C(N(CC(=O)O)CC(N)C)CN1C=C(C(=O)NC1=O)C | InChi: | InChI=1S/C12H18N4O5/c1-7-3-16(12(21)14-11(7)20)5-9(17)15(4-8(2)13)6-10(18)19/h3,8H,4-6,13H2,1-2H3,(H,18,19)(H,14,20,21)/t8-/m0/s1 | Definition date: | 2010-04-26 | Last modified: | 2023-11-03 | Identifier: | N-[(2S)-2-aminopropyl]-N-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]glycine |
|
![IAE IAE](https://data.pdbj.org/pdbjplus/data/cc/svg/IAE.svg) | IAE | Name: | (2S)-2-azanyl-4-[4-(trifluoromethyl)phenyl]butanoic acid | Formula: | C11 H12 F3 N O2 | SMILES: | N[CH](CCc1ccc(cc1)C(F)(F)F)C(O)=O | InChi: | InChI=1S/C11H12F3NO2/c12-11(13,14)8-4-1-7(2-5-8)3-6-9(15)10(16)17/h1-2,4-5,9H,3,6,15H2,(H,16,17)/t9-/m0/s1 | Definition date: | 2022-06-23 | Last modified: | 2023-11-03 | Release date: | 2023-07-26 | Identifier: | (2~{S})-2-azanyl-4-[4-(trifluoromethyl)phenyl]butanoic acid |
|
![IAM IAM](https://data.pdbj.org/pdbjplus/data/cc/svg/IAM.svg) | IAM | Name: | 4-[(ISOPROPYLAMINO)METHYL]PHENYLALANINE | Formula: | C13 H20 N2 O2 | SMILES: | O=C(O)C(N)Cc1ccc(cc1)CNC(C)C | InChi: | InChI=1S/C13H20N2O2/c1-9(2)15-8-11-5-3-10(4-6-11)7-12(14)13(16)17/h3-6,9,12,15H,7-8,14H2,1-2H3,(H,16,17)/t12-/m0/s1 | Definition date: | 2004-11-19 | Last modified: | 2023-11-03 | Identifier: | 4-{[(1-methylethyl)amino]methyl}-L-phenylalanine |
|